Akli's third-quarter operating revenue was 168 million yuan, down 24.87 percent year on year
Wuxi Acoli, a domestic supplier of polyether amines, announced its third quarter 2022 financial results. In the third quarter, Akeli achieved operating income of 168 million yuan, decreasing 24.87% year on year, net profit attributable to the mother realized 29.64 million yuan, increasing 67.92% year on year, withholding non-net profit attributable to the mother 28.66 million yuan, increasing 68.76% year on year. From January to September this year, the first three quarters of Akli accumulated operating income of 577 million yuan, a year-on-year decrease of 9.73%, net profit to the mother of 104 million yuan, a year-on-year increase of 52.05%, deduction of non-maternal net profit of 102 million yuan, a year-on-year increase of 53.19%. In the other quarter to the third quarter, Arklee's cash flow from operating activities was 139 million yuan, an increase of 17.31% compared to the same period last year.
As for the decline in revenue, Acoli attributed the main reason to a slight decline in product sales due to the lack of road transportation during the pandemic. The increase of net profit is mainly due to the decrease of raw material prices and the increase of profit margin.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF Approves €1 Billion Share Buyback Program as Chemical Giant Prioritizes Capital Discipline
-
BASF, Sinopec Forge Green Alliance to Power Nanjing Site with Certified Bio-Methane
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Huntsman’s Rotterdam Plant Hit by Unexpected Shutdown, Q4 EBITDA Takes a $10M Hit
-
Europe’s Chemical Industry in the Ice Age: Profits Evaporating, Plants Shutting Down, Capital Fleeing—A Systemic Collapse Is Underway
-
Dafeng Haijianuo’s RMB 246 Million Technical Revamp Project Takes Shape, with Multiple Production Lines for Vitamin K1, Folic Acid, and Others Under Construction
-
$15 Billion Invested in China: AstraZeneca Builds an “Innovation Hub” While Some Are Still Waiting for the Windfall
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
Recommend Reading
-
Beiersdorf Launches Eucerin Skincare Brand in Japan
-
Korea’s Petrochemical Pivot: Industry Embraces Historic Restructuring to Slash Overcapacity
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
$1.35 Billion! AkzoNobel to Sell Decorative Paints Business in Southeast Asia and Australia to Nippon Paint
-
Costs Rise, Adipic Acid Prices Continue to Soar
-
Business Society October 12, 2026 DMF Trend Analysis: Slightly Strong
-
Business Society October 13, 2026 Melamine Trend Analysis: Clear Decline
-
Geopolitical Expectations Reversal Leads to Severe Oil Market Volatility, Oil Prices Plunge Over 11%
-
Business Society October 12, 2026 Ethanol Trend Analysis: Clear Uptrend
- Hot Searches
- bioglutide peptide for sale
- structure of isopropanol
- 4-anisic acid
- amoxicillin potassium clavulanate info
- sr 17018 buy online cheap
- sigmoid.volvulus
- trifluoroacetic acid
- urea 46 price per ton today
- creatine monohydrate wikipedia
- bioglutide for sale
- retatrutide buy online usa
- compounded retatrutide